Human FOXP3 and cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2010174.pdf
Reference94 articles.
1. Akbar AN, Vukmanovic-Stejic M, Taams LS, Macallan DC . (2007). The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 7: 231–237.
2. Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC et al. (2005). The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 115: 3276–3284.
3. Alvaro T, Lejeune M, Salvado MT, Bosch R, Garcia JF, Jaen J et al. (2005). Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 11: 1467–1473.
4. Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H et al. (2006). Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 12: 465–472.
5. Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL et al. (2006). Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24: 5373–5380.
Cited by 118 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Participation of T cells in generating immune protection against cancers;Pathology - Research and Practice;2024-10
2. The prognostic value of Th17/Treg cell in cervical cancer: a systematic review and meta-analysis;Frontiers in Oncology;2024-09-11
3. Prognostic Value of Insulin Growth Factor-Like Receptor 1 (IGFLR1) in Stage II and III Colorectal Cancer and Its Association with Immune Cell Infiltration;Applied Biochemistry and Biotechnology;2024-08-14
4. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges;Molecular Cancer;2024-05-20
5. Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic review;Discover Oncology;2024-04-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3